Mid-luteal Phase Synchronization of Ovarian Folliculogenesis in Women
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
We hypothesize that administration of an aromatase inhibitor (AI) and hormonal contraceptives
(HC) in the mid-luteal phase of the menstrual cycle will result in atresia of the follicles
in the extant wave and cause synchronous re-emergence of a new follicular wave. We anticipate
that this will provide us with information to facilitate the development of a new method for
ovarian synchronization; a safer, more effective ovulation induction therapy; a new method
for emergency contraception; and a greater understanding of human folliculogenesis.